Devyser achieves breakthrough in the US with cystic fibrosis NGS test
Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
News | July 3, 2018
Devyser is pleased to announce the publication of a new whitepaper Familial Hypercholesterolemia: Genetic Diagnosis and Cascade Testing Using NGS
The 6th in our Expert Review series, this paper is co-authored by Peter Benedek and Kristina Duvefelt, of Karolinska University Hospital, Stockholm.
The paper is a guide to conducting testing using NGS, and the benefits of implementing cascade screening for FH, which is a dominant yet highly underdiagnosed heriditary disorder. Affected individuals are affected by high levels of LDL-cholesterol, and early onset cardiovascular disease and death.
Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
Read More
Devyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
Read More
“Devyser is able to report strong sales growth and record high gross margins for the fourth...
Read More
Read More